INSOMNIA is the #4 most commonly reported adverse reaction for SODIUM OXYBATE, manufactured by Jazz Pharmaceuticals, Inc.. There are 3,319 FDA adverse event reports linking SODIUM OXYBATE to INSOMNIA. This represents approximately 2.6% of all 126,117 adverse event reports for this drug.
SODIUM OXYBATE has an overall safety score of 85 out of 100. Patients taking SODIUM OXYBATE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
INSOMNIA3,319 of 126,117 reports
INSOMNIA is a less commonly reported adverse event for SODIUM OXYBATE, but still significant enough to appear in the safety profile.
Other Side Effects of SODIUM OXYBATE
In addition to insomnia, the following adverse reactions have been reported for SODIUM OXYBATE:
INSOMNIA has been reported as an adverse event in 3,319 FDA reports for SODIUM OXYBATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is INSOMNIA with SODIUM OXYBATE?
INSOMNIA accounts for approximately 2.6% of all adverse event reports for SODIUM OXYBATE, making it a notable side effect.
What should I do if I experience INSOMNIA while taking SODIUM OXYBATE?
If you experience insomnia while taking SODIUM OXYBATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.